Clinical Trial Update: Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on a new ophthalmic formulation of bimatoprost for open-angle glaucoma and ocular hypertension; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Bimatoprost (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-03-30